Home › NY Department of Health Approves Personalis' ACE Exome Testing

NY Department of Health Approves Personalis' ACE Exome Testing

Apr 24, 2017

NEW YORK (GenomeWeb) – Diagnostic sequencing firm Personalis announced it has received approval from the New York State Department of Health for two clinical tests based on its ACE Exome for Inherited Disorders offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Regulatory News

  1. LabCorp, Sysmex, Diazyme, and Others Receive FDA Clearances for Assays, Diagnostic Systems in October

  2. Health Canada Approves Two BCR-ABL Tests

  3. Diagnostics Developers Rapidly Utilizing New Payment Codes Established by PAMA

    Premium

  4. Siemens Healthineers Liver Fibrosis Test Gets FDA Breakthrough Device Designation

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.